Evidence map›Paper›PMID 25393872›Full record

ArticlePloS one2014

Hidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesis.

Monika Lewinska, Peter Juvan, Martina Perse, Jera Jeruc, Spela Kos, Gregor Lorbek, Ziga Urlep, Rok Keber, Simon Horvat, Damjana Rozman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Monika LewinskaCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia.
Peter JuvanCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia.
Martina PerseMedical Experimental Centre, Institute of Pathology, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia.
Jera JerucMedical Experimental Centre, Institute of Pathology, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia.
Spela KosCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia; Institute of Oncology Ljubljana, Zaloška cesta 2, SI-1000, Ljubljana, Slovenia.
Gregor LorbekCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia.
Ziga UrlepCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia.
Rok KeberDepartment of Animal Science, Biotechnical Faculty, University of Ljubljana, Groblje 3, 1230, Domžale, Slovenia.
Simon HorvatDepartment of Animal Science, Biotechnical Faculty, University of Ljubljana, Groblje 3, 1230, Domžale, Slovenia; National Institute of Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia.
Damjana RozmanCenter for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, SI-1000, Ljubljana, Slovenia.
University of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined the genotype-phenotype interactions of Cyp51+/- mice carrying one functional allele of lanosterol 14α-demethylase from cholesterol biosynthesis. No distinct developmental or morphological abnormalities were observed by routine visual inspection of Cyp51+/- and Cyp51+/+ mice and fertility was similar. We further collected a large data-set from female and male Cyp51+/- mice and controls fed for 16 weeks with three diets and applied linear regression modeling. We used 3 predictor variables (genotype, sex, diet), and 39 response variables corresponding to the organ characteristics (7), plasma parameters (7), and hepatic gene expression (25). We observed significant differences between Cyp51+/- and wild-type mice in organ characteristics and blood lipid profile. Hepatomegaly was observed in Cyp51+/- males, together with elevated total and low-density lipoprotein cholesterol. Cyp51+/- females fed high-fat, high-cholesterol diet were leaner and had elevated plasma corticosterone compared to controls. We observed elevated hepatocyte apoptosis, mitosis and lipid infiltration in heterozygous knockouts of both sexes. The Cyp51+/- females had a modified lipid storage homeostasis protecting them from weight-gain when fed high-fat high-cholesterol diet. Malfunction of one Cyp51 allele therefore initiates disease pathways towards cholesterol-linked liver pathologies and sex-dependent response to dietary challenge.

Indexed as

CholesterolGenetic Predisposition to DiseaseHepatomegalyHeterozygoteSex CharacteristicsSterol 14-DemethylaseAnimalsApoptosisDietary FatsFemaleHepatocytesMaleMiceMice, KnockoutMitosisCholesterolCyp51 protein, mouseDietary FatsSterol 14-Demethylase

Identifiers

PMID25393872
PMCPMC4231084
OpenAlexW2031948407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.